Align Formate-dependent phosphoribosylglycinamide formyltransferase; 5'-phosphoribosylglycinamide transformylase 2; Formate-dependent GAR transformylase; GAR transformylase 2; GART 2; Non-folate glycinamide ribonucleotide transformylase; Phosphoribosylglycinamide formyltransferase 2; EC 2.1.2.- (characterized)
to candidate WP_012035876.1 RCI_RS07775 formate-dependent phosphoribosylglycinamide formyltransferase
Query= SwissProt::P33221 (392 letters) >NCBI__GCF_000063445.1:WP_012035876.1 Length = 426 Score = 288 bits (737), Expect = 2e-82 Identities = 180/407 (44%), Positives = 242/407 (59%), Gaps = 24/407 (5%) Query: 3 LLGTALRPAATRVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVINML 62 +LGT A ++M LG+GELGKE IE QR+G+E++AVDRYA++P M VAHRS+V NM Sbjct: 8 VLGTPYANGA-KLMFLGAGELGKETMIEAQRMGIEIVAVDRYANSPGMQVAHRSYVTNMK 66 Query: 63 DGDALRRVVELEKPHYIVPEIEAIATDMLIQLEEEGLNVVPCARATKLTMNREGIRRLAA 122 AL +VE EKP I+PEIEAI TD L +LE+EG V PCA A M+RE +R A Sbjct: 67 SERALLAIVEKEKPDAIIPEIEAINTDTLFKLEKEGFFVAPCANAVWTAMHRERLRE-AI 125 Query: 123 EELQLPTSTYRFADSESLFREAVADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKYAQ 182 TS Y +A F+ A IG+PC+ KP+MSSSGKG ++S++ + +A+K A Sbjct: 126 ASTGARTSKYEYATDLESFKAACKKIGFPCVSKPIMSSSGKGSYVLKSSKDVEKAFKEAA 185 Query: 183 QGGRAGAGRVIVEGVVKFDFEITLLTVSAVDG-----VHFCAPVGHRQEDGDYRESWQP- 236 + R + ++IVE + FD EIT L+V ++G F P+GH Q +GDY SW P Sbjct: 186 K-ARGSSDKIIVEEFIDFDVEITALSVRYLNGKGKPESKFVRPLGHYQIEGDYHASWHPW 244 Query: 237 -----QQMSPLALERAQEIARKVVLALGGYGLFGVELFV--CGDEVIFSEVSPRPHDTGM 289 +++ L E + A +++ LGGYGLF E+FV +V +E + RPHDTG+ Sbjct: 245 TDATDKKIDKLEKE-IYDYAGRIMDKLGGYGLFAHEMFVDTKNGKVYANETACRPHDTGL 303 Query: 290 VTLISQDL--SEFALHVRAFLGLPVG----GIRQYGPAASAVILPQLTSQNVTFDNVQNA 343 VT+ S SEFALH +A LG+P+ I+ AAS VIL F V A Sbjct: 304 VTIASMPFGYSEFALHAKAVLGIPIACEGKVIQPRSTAASHVILSHTEGWYPQF-KVDGA 362 Query: 344 VGADLQIRLFGKPEIDGSRRLGVALATAESVVDAIERAKHAAGQVKV 390 D + +FGKPE RRLGV LATA +V DA ++A+ AA VKV Sbjct: 363 YAPDTNVLIFGKPEAYEERRLGVVLATAGTVEDAKKKAQKAAHTVKV 409 Lambda K H 0.320 0.136 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 399 Number of extensions: 18 Number of successful extensions: 8 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 392 Length of database: 426 Length adjustment: 31 Effective length of query: 361 Effective length of database: 395 Effective search space: 142595 Effective search space used: 142595 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory